Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 1

Status

Completed 44Unknown 27Recruiting 13Withdrawn 12Terminated 8Active not recruiting 8Not yet recruiting 6

Sponsor Class

OTHER 6

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Gastrointestinal 20Thoracic 17Breast 13Head & Neck 12Genitourinary 12CNS 9Lymphoid 6Gynecologic 6Tumor-Agnostic 4Sarcoma 2Other hematologic neoplasm 1

Conditions

Uterine Cervical Neoplasms 4Radiation Injuries 1Pelvic Neoplasms 1Head and Neck Neoplasms 1Cervical Cancer by FIGO Stage 2018 1

Interventions

Paclitaxel 24Carboplatin 18Bevacizumab 14Cisplatin 12pembrolizumab 7fluzoparib 7Drug Therapy 7Radiotherapy 6camrelizumab 5apatinib 5Topotecan 5Magnetic Resonance Spectroscopy 5Injections 5liposomal doxorubicin 4lenvatinib 4famitinib 4Tirzepatide 4Specimen Handling 4Platinum 4Observation 4Gemcitabine 4Brachytherapy 4toripalimab 3olaparib 3dostarlimab 3anlotinib 3Watchful Waiting 3Therapeutics 3Surveys and Questionnaires 3Neoadjuvant Therapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Not yet recruiting × Radiotherapy × Gynecologic × Clear all
NCT05521997 2026-03-13

Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer

Washington University School of Medicine

Phase 2 Not yet recruiting
42 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT07461142 2026-03-10

RETHEMCOL

Institut Paoli-Calmettes

Phase NA Not yet recruiting
72 enrolled
Gynecologic

Cervical Cancer by FIGO Stage 2018

NCT07129525 2025-08-19

HOPE

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Not yet recruiting
80 enrolled
GynecologicHead & Neck

Head and Neck Neoplasms, Pelvic Neoplasms, Radiation Injuries

NCT06426056 2024-05-23

Nab-Paclitaxel Plus Cisplatin With Concurrent Radiotherapy for Patients With Locally Advanced Cervical Cancer: A Multicentre, Single-arm, Phase II Trial.

Peking University Third Hospital

Phase 2 Not yet recruiting
64 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT06128460 2023-11-30

Adjuvant Chemoradiotherapy Followed by Zimberelimab for Locally Advanced Cervical Cancer.

Obstetrics & Gynecology Hospital of Fudan University

Phase 2 Not yet recruiting
24 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT06039891 2023-09-15

Nimotuzumab Plus Tislelizumab for Recurrent and Metastatic Cervical Cancer

Peking Union Medical College Hospital

Phase 2 Not yet recruiting
55 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡